company background image
WELL

WELL Health Technologies TSX:WELL Stock Report

Last Price

CA$3.32

Market Cap

CA$738.0m

7D

4.7%

1Y

-59.3%

Updated

27 Jun, 2022

Data

Company Financials +
WELL fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance0/6
Financial Health3/6
Dividends0/6

WELL Stock Overview

WELL Health Technologies Corp. operates as a practitioner focused digital health company in Canada, the United States, and internationally.

WELL Health Technologies Competitors

Price History & Performance

Summary of all time highs, changes and price drops for WELL Health Technologies
Historical stock prices
Current Share PriceCA$3.32
52 Week HighCA$8.86
52 Week LowCA$3.04
Beta1.31
1 Month Change-12.63%
3 Month Change-33.07%
1 Year Change-59.31%
3 Year Change260.87%
5 Year Change1,560.00%
Change since IPO2,041.94%

Recent News & Updates

May 31
WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 43% Above Its Share Price

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 43% Above Its Share Price

How far off is WELL Health Technologies Corp. ( TSE:WELL ) from its intrinsic value? Using the most recent financial...

Shareholder Returns

WELLCA HealthcareCA Market
7D4.7%3.4%0.3%
1Y-59.3%-33.7%-4.0%

Return vs Industry: WELL underperformed the Canadian Healthcare industry which returned -33.7% over the past year.

Return vs Market: WELL underperformed the Canadian Market which returned -4% over the past year.

Price Volatility

Is WELL's price volatile compared to industry and market?
WELL volatility
WELL Average Weekly Movement8.1%
Healthcare Industry Average Movement8.5%
Market Average Movement10.0%
10% most volatile stocks in CA Market17.3%
10% least volatile stocks in CA Market4.4%

Stable Share Price: WELL is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: WELL's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20101,507Hamed Shahbazihttps://www.well.company

WELL Health Technologies Corp. operates as a practitioner focused digital health company in Canada, the United States, and internationally. It offers end-to-end omni-channel patient services, including primary care; physiotherapy, occupational therapy, chiropractic, dietary, mental health counselling, and sleep related services; specialized care, including gastroenterologists; diagnostic services related to cardiology, women’s health, and bone/muscle health and cancer diagnostics; and telehealth services. The company also operates OSCAR Pro, an electronic medical records platform; telehealth platforms, including Tia Health, VirtualClinic+, VirtuelMed, Adracare, and Circle Medical; Apps.health, a digital health app marketplace; Insig, which offers virtual care and digital patient engagement services; billing and revenue cycle management solutions for billing and back-office services comprising billing-as-a-service outsourcing services to doctors; and cybersecurity protection and patient data privacy solutions.

WELL Health Technologies Fundamentals Summary

How do WELL Health Technologies's earnings and revenue compare to its market cap?
WELL fundamental statistics
Market CapCA$738.01m
Earnings (TTM)-CA$44.33m
Revenue (TTM)CA$403.27m

1.8x

P/S Ratio

-16.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
WELL income statement (TTM)
RevenueCA$403.27m
Cost of RevenueCA$190.23m
Gross ProfitCA$213.04m
Other ExpensesCA$257.38m
Earnings-CA$44.33m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.20
Gross Margin52.83%
Net Profit Margin-10.99%
Debt/Equity Ratio44.7%

How did WELL perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is WELL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for WELL?

Other financial metrics that can be useful for relative valuation.

WELL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.9x
Enterprise Value/EBITDA20.2x
PEG Ration/a

Price to Sales Ratio vs Peers

How does WELL's PS Ratio compare to its peers?

WELL PS Ratio vs Peers
The above table shows the PS ratio for WELL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average2.2x
AND Andlauer Healthcare Group
3.7x5.4%CA$1.8b
VMD Viemed Healthcare
1.9x11.1%CA$289.9m
DNTL dentalcorp Holdings
2x14.1%CA$2.0b
QIPT Quipt Home Medical
1.3x21.8%CA$196.0m
WELL WELL Health Technologies
1.8x12.1%CA$738.0m

Price-To-Sales vs Peers: WELL is good value based on its Price-To-Sales Ratio (1.8x) compared to the peer average (2.2x).


Price to Earnings Ratio vs Industry

How does WELL's PE Ratio compare vs other companies in the CA Healthcare Industry?

Price-To-Sales vs Industry: WELL is expensive based on its Price-To-Sales Ratio (1.8x) compared to the Canadian Healthcare industry average (1.4x)


Price to Sales Ratio vs Fair Ratio

What is WELL's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

WELL PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.8x
Fair PS Ratio2.4x

Price-To-Sales vs Fair Ratio: WELL is good value based on its Price-To-Sales Ratio (1.8x) compared to the estimated Fair Price-To-Sales Ratio (2.4x).


Share Price vs Fair Value

What is the Fair Price of WELL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: WELL (CA$3.32) is trading below our estimate of fair value (CA$5.67)

Significantly Below Fair Value: WELL is trading below fair value by more than 20%.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate WELL's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is WELL Health Technologies forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


120.4%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: WELL is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: WELL is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: WELL is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: WELL's revenue (12.1% per year) is forecast to grow faster than the Canadian market (6.9% per year).

High Growth Revenue: WELL's revenue (12.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if WELL's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Past Performance

How has WELL Health Technologies performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-55.8%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: WELL is currently unprofitable.

Growing Profit Margin: WELL is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: WELL is unprofitable, and losses have increased over the past 5 years at a rate of 55.8% per year.

Accelerating Growth: Unable to compare WELL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: WELL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-68.2%).


Return on Equity

High ROE: WELL has a negative Return on Equity (-3.66%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is WELL Health Technologies's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: WELL's short term assets (CA$121.0M) do not cover its short term liabilities (CA$149.6M).

Long Term Liabilities: WELL's short term assets (CA$121.0M) do not cover its long term liabilities (CA$387.3M).


Debt to Equity History and Analysis

Debt Level: WELL's net debt to equity ratio (39.6%) is considered satisfactory.

Reducing Debt: WELL had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: WELL has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if WELL has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Dividend

What is WELL Health Technologies's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate WELL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate WELL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if WELL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if WELL's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as WELL has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

3.2yrs

Average management tenure


CEO

Hamed Shahbazi (46 yo)

4.08yrs

Tenure

CA$5,178,000

Compensation

Mr. Hamed Shahbazi, B.Sc serves as Venture Partner at Pender Ventures, and serves as a Director at Hire Technologies Inc. (formerly known as Bay Talent Group Inc.) (formerly known as Danacore Industries In...


Leadership Team

Experienced Management: WELL's management team is considered experienced (3.2 years average tenure).


Board Members

Experienced Board: WELL's board of directors are considered experienced (4.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: WELL insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.5%.


Top Shareholders

Company Information

WELL Health Technologies Corp.'s employee growth, exchange listings and data sources


Key Information

  • Name: WELL Health Technologies Corp.
  • Ticker: WELL
  • Exchange: TSX
  • Founded: 2010
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: CA$738.009m
  • Shares outstanding: 222.29m
  • Website: https://www.well.company

Number of Employees


Location

  • WELL Health Technologies Corp.
  • 322 Water Street
  • Suite 200
  • Vancouver
  • British Columbia
  • V6B 1B6
  • Canada

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/27 00:00
End of Day Share Price2022/06/27 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.